COMPOSITION CONTAINING LACTIC ACID AND LACTOFERRIN Russian patent published in 2010 - IPC A61K31/185 A61K38/16 A61P13/00 A61P15/00 A61P31/04 A61P31/10 

Abstract RU 2398575 C2

FIELD: medicine.

SUBSTANCE: invention is characterised by a composition containing lactic acid and lactoferrin, or its peptide fragment, for treatment and/or prevention of the urogenital involvements, and by application of said composition for preparing a drug for treatment and/or prevention of the urogenital involvements, and also a method of treatment thereof. The method for prevention and/or treatment of the urogenital involvements caused by a bacterial or fungal infection, involves administration to the patient of a pharmaceutically effective amount of the composition containing lactic acid, or its salt, and lactoferrin, or its peptide fragment where said peptide fragment is based on an antimicrobial site of a lactoferrin molecule from an N-end.

EFFECT: invention provides the antimicrobial effect of application in the method for prevention and/or treatment with using said composition.

25 cl, 4 tbl, 8 dwg, 4 ex

Similar patents RU2398575C2

Title Year Author Number
PROBIOTIC STRAINS OF Lactobacillus (VARIANTS) AND THEIR USING 2003
  • Brennstad Gunnar
  • Bransborg Ehrik
RU2316586C2
USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS 2013
  • Nivole Adrian
RU2667122C2
EFFERVESCENT COMPOSITION IN SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR TREATING VAGINAL INFECTIONS 2012
  • Monya Dzhovanni
  • Strotstsi Dzhan Paolo
  • Monya Luka
RU2587717C2
BACTERIUM LACTOBACILLUS RHAMNOSUS FOR THE TREATMENT OF, FOR EXAMPLE, BACTERIAL VAGINOSIS 2016
  • Khenoll Kuadros Mariya Empar
  • Kasinos Ramo Beatris
  • Silva Angulo Ankhela
  • Ramon Vidal Daniel
  • Khenoves Martines Salvador
RU2758109C2
CULTURE MEDIUM FOR ISOLATION AND CULTIVATION OF LACTOBACILLUS INERS AND OTHER REPRESENTATIVES OF THE VAGINAL MICROBIOTA 2022
  • Podkopaev Iaroslav Vasilevich
  • Domotenko Liubov Viktorovna
  • Mikhanoshina Natalia Vladimirovna
  • Priputnevich Tatiana Valerevna
  • Shepelin Anatolii Prokopevich
RU2794804C1
PEPTIDES, DETACHED FROM HUMAN LACTOFERRIN, AND USE THEREOF 2012
  • Makhlapuu Margit
  • Bern Kamilla
  • Shestrand Veronika
  • Valse Bern
  • Svensson Bo
RU2593757C2
USE OF TOTAROL AND PHARMACEUTICAL COMPOSITION CONTAINING TOTAROL 2018
  • Tsentsyara Mariush
  • Vzhosek Artur
RU2812223C2
LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF 2013
  • Nivole Adrian
RU2661102C2
NOVEL SYNTHETIC PEPTIDES AND USE THEREOF 2012
  • Makhlapuu Margit
  • Bern Kamilla
  • Shestrand Veronika
  • Valse Bern
  • Svensson Bo
RU2596393C2
PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN 2016
  • Priputnevich Tatyana Valerevna
  • Melkumyan Alina Rantikovna
  • Lyubasovskaya Lyudmila Anatolevna
  • Muraveva Vera Vasilevna
  • Zubkov Viktor Vasilevich
  • Abramov Vyacheslav Mikhajlovich
  • Khlebnikov Valentin Sergeevich
  • Kosarev Igor Vasilevich
  • Sakulin Vadim Konstantinovich
  • Vasilenko Raisa Nikolaevna
  • Machulin Andrej Valerievich
  • Karlyshev Andrej Vladimirovich
  • Samojlenko Vladimir Aleksandrovich
  • Melnikov Vyacheslav Gennadevich
  • Uverskij Vladimir Nikolaevich
RU2641258C1

RU 2 398 575 C2

Authors

Mattsbju-Bal'Tzer Inger

Andersk B'Ern

Dates

2010-09-10Published

2005-06-23Filed